Prescription Monitoring Program (PMP) Information
To manage the technical aspects of the program, the Board has partnered with Appriss, Inc. They receive the transaction reports from all the dispensers, house the data on servers owned by the Board, and host the web portal for authorized direct access users. Appriss has also authored technical assistance documents as provided below.
Annual Program Reports: 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Report of Performance Audit for 2013-2016 by Louisiana Legislative Auditor
NEW - February 2019
The Prescription Monitoring Program is implementing a statewide comprehensive platform for healthcare professionals to review patients' controlled substance prescription history more quickly and efficiently. The goal of the integration project is to minimize any workflow disruption by providing near-instant and seamless access to critical controlled substance prescription history information to both prescribers and pharmacists. This platform utilizes current PMP prescription data and transfers it into electronic health records (EHR) and pharmacy management systems. This statewide integration is a key component of Louisiana's ongoing efforts to address the opioid crisis. Accessing and viewing a patient's PMP report obtained through the integration platform complies with Louisiana's PMP Mandatory Use Law (R.S. 40:978). EHR and pharmacy management system representatives seeking connection to the integration platform should complete the Louisiana NarxCare EHR & Pharmacy Management System Integration Request Form.
Information for Dispensers
Effective June 2, 2016 the reporting of eligible prescription transactions (Schedules II through V and drugs of concern) to the Louisiana PMP database must be submitted to the Appriss Clearinghouse. This Louisiana Data Submission Dispenser Guide explains the process of registering and transmitting the required data.
Information for Direct Users
Prescribers who wish to obtain access to the PMP must visit https://louisiana.pmpaware.net/login and select the Create an Account link to begin the process. The prescriber will be required to provide specific information unique to him in addition to the Individual Access Code provided to him by the Board for immediate access.
Prescribers who recently acquired a new Louisiana Controlled Dangerous Substance (CDS) License will receive the Individual Access Code from the Board once a Drug Enforcement Administration (DEA) registration number is acquired.
Once the PMP account has been established, the prescriber will receive an approval email, along with an email verification request. These emails will come from firstname.lastname@example.org Please adjust any email filters in place to recognize that address as a valid email address.
For those prescribers who experience an entry error and cannot complete the online registration process, please contact the Prescription Monitoring Program (PMP) for assistance at (225) 925-6496, option "2".
Pharmacists who wish to obtain access the PMP must visit https://louisiana.pmpaware.net/login and select the Create an Account link to begin the process. When the process has been completed, the site will prompt the pharmacist to complete a paper application form and mail it to the Board office. Board staff can only process the original notarized document which must be accompanied by a copy of the pharmacist's driver's license or state-issued identification card. In the event Board staff requires any additional information, they will email the pharmacist with instructions.
User Support Resources
For detailed assistance, please refer to the User Registration Process Tutorial.
For more detailed assistance for the AWARxE program, please consult the AWARxE User Support Manual [v2.1 - Feb 2019]
For your convenience, we have constructed a Quick Reference Guide for Patient Data Search.
NarxCare User Tutorials: PMP users can learn how to navigate and better understand the NarxCare platform with interactive tutorials from Appriss. Follow along with Generic Navigation or NarxCare Interpretation to become familiar with Louisiana's NarxCare platform.